Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Secretin Receptor

  • Laurence J. MillerEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101788



Historical Background

Secretin and the secretin receptor hold special places in history, with the discovery of the biological activity of this peptide hormone by Bayliss and Starling in 1902 representing the first humoral mediator identified and launching the field of endocrinology and with the description of this receptor by Ishihara et al. in 1991 representing the first class B G protein-coupled receptor (GPCR) identified. Both of these events marked the beginning of exciting and important chapters in biomedical history. The class B GPCRs comprise a small family within this superfamily, including receptors for only a small number of moderate length peptides (also including receptors for vasoactive intestinal polypeptide, pituitary adenylate cyclase-activating peptide, glucagon, glucagon-like peptides 1 and 2, glucose-dependent insulinotropic polypeptide, calcitonin, calcitonin gene-related peptide, amylin, adrenomedullin, parathyroid hormone, parathyroid...

This is a preview of subscription content, log in to check access.


  1. Bortolato A, Dore AS, Hollenstein K, Tehan BG, Mason JS, Marshall FH. Structure of Class B GPCRs: new horizons for drug discovery. Br J Pharmacol. 2014;171:3132–45.  https://doi.org/10.1111/bph.12689.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Chu JY, Cheng CY, Lee VH, Chan YS, Chow BK. Secretin and body fluid homeostasis. Kidney Int. 2011;79:280–7.  https://doi.org/10.1038/ki.2010.397.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Dong M, Lam PC, Pinon DI, Hosohata K, Orry A, Sexton PM, et al. Molecular basis of secretin docking to its intact receptor using multiple photolabile probes distributed throughout the pharmacophore. J Biol Chem. 2011;286:23888–99.  https://doi.org/10.1074/jbc.M111.245969.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Gao F, Harikumar KG, Dong M, Lam PC, Sexton PM, Christopoulos A, et al. Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor. Mol Pharmacol. 2009;76:264–74.  https://doi.org/10.1124/mol.109.055756.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Hollenstein K, de Graaf C, Bortolato A, Wang MW, Marshall FH, Stevens RC. Insights into the structure of class B GPCRs. Trends Pharmacol Sci. 2014;35:12–22.  https://doi.org/10.1016/j.tips.2013.11.001.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Lee LT, Ng SY, Chu JY, Sekar R, Harikumar KG, Miller LJ, et al. Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex. FASEB J. 2014;28:2632–44.  https://doi.org/10.1096/fj.13-246868.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Miller LJ, Dong M. The orthosteric agonist-binding pocket in the prototypic class B G-protein-coupled secretin receptor. Biochem Soc Trans. 2013;41:154–8.  https://doi.org/10.1042/BST20120204.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Miller LJ, Dong M, Harikumar KG. Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor. Br J Pharmacol. 2012;166:18–26.  https://doi.org/10.1111/j.1476-5381.2011.01463.x.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Siu FK, Lam IP, Chu JY, Chow BK. Signaling mechanisms of secretin receptor. Regul Pept. 2006;137:95–104.  https://doi.org/10.1016/j.regpep.2006.02.011.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Pharmacology and Experimental Therapeutics and Department of Internal Medicine, Division of GastroenterologyMayo ClinicScottsdaleUSA